undamentalytics Newsletter
Sign in

Cabot Corp (CBT) stock

Add to watchlist

Add holding +

NYSE: CBT NYSE Specialty Chemicals Next results ~February 2, 2027

B Fundamentals grade

Cabot Corp is a US-listed company in the specialty chemicals industry. Its financial year ends in September.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$99

Cash-flow model

Base case. Range ~$69–$140 across our lower- and higher-growth cases (-3%–7% a year).

Price vs value

Modestly undervalued

The price is inside our value range, 24% below our base value.

Price used: $75.72, November 2, 2026

Cabot Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 1 selling0 purchases and 3 sales by directors and officers, last 12 monthsInsider trades
  • Funds200 adding, 141 cuttingOf 48 active managers that changed their stake, 24 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Cabot files

Where Cabot stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $3.63bn, down 4.7% on a year earlier, a smaller fall than the 8.5% decline a quarter earlier. That puts it 20 of 20 for growth among the specialty chemicals companies we cover. Free-cash-flow margin fell to 7.7% from 9.1% a year earlier. Operating margin narrowed to 13.6% from 16.6%. The diluted share count is down 3.7% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades C+. It passes 4 of our 6 financial-health checks. Our cash-flow model value is $96.25 a share, against a share price of $73.03. At that price, our model says the market is pricing in cash flow shrinking about 1.5% a year for five years, slower than the 1.3% a year revenue growth it has delivered.

Source: 10-Q filed August 4, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 2, 2027 (estimated)

Cabot Corp's trailing-twelve-month revenue fell 4.7% year on year, with a free-cash-flow margin of 7.7%. Where it stands out: change in share count of -3.7% ranks 2 of 37 specialty chemicals companies we cover. Where it lags: revenue growth of -4.7% ranks 34 of 42 specialty chemicals companies we cover.

Our discounted-cash-flow model values the business at ~$99 per share in the base case (~$69–$140 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 19.3% while net income fell 55.3%: a 36pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Priced below our value. The share price of $75.72 is 31% below our value per share of $99.
  • Shrinking share count. Diluted shares fell 3.7% in a year, so each share owns more of the business.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Revenue shrinking. Revenue fell 4.7% over the last 12 months.
  • Margins narrowing. Operating margin is down 3.1 points on a year ago.
  • Insiders selling. 1 insiders sold $20M of stock over the past 365 days and none bought (0% under pre-set trading plans).
  • Gross margin slipping. Gross margin is down 2.5 points on a year ago.
  • Heavily shorted. 13.0% of the shares available to trade are sold short (11.8 days of average volume to cover).

Latest results: FY2026 Q3

Filed August 4, 2026
Earnings per share
$1.61 against an average estimate of $1.54: beat by 4.6%
Revenue
$982m, up 6.4% on a year earlier
Share reaction
-6.9% in the first session after the results on August 3, 2026, against +3.3% for the S&P 500
Guidance given
adjusted EPS $6.15 to $6.45 (fiscal 2026); EBITDA $40m (fiscal 2026)
Next report
November 2, 2026; average EPS estimate $1.59

Cabot's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+1.7%
  • 1 week+3.9%
  • 1 month-1.6%
  • This year+16.2%
  • 1 year+14.9%
  • 5 years+48.3%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$3.6B
Operating margin
13.6%
Net margin
5.2%
EPS (TTM, diluted)
$3.61

Growth

Revenue growth
−4.7%
Change in growth rate
+3.8 pts
Share count change
−3.7%

Cash

Free cash flow (TTM)
$281M
FCF margin
7.7%
Stock pay % of revenue
0.5%

Earnings

Last results
November 2, 2026
Next results (est.)
February 2, 2027

News & updates

Updated November 3, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Leadership
  3. Insider trade
  4. Announcement
  5. Announcement
  6. Insider trade
  7. Results
  8. Guidance
  9. Leadership

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Cabot Corp valuation models and calculator

What the price is pricing in

The share price implies cash flow shrinking about 1.7% a year for five years.That is close to the 1.3% a year revenue growth Cabot has delivered.

  • Priced in-1.7%
  • Last 12 months-4.7%
  • 3 years a year-3.8%
  • 5 years a year1.3%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($72.14, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Buy12-month view
12-month price target
~$99
Price used
$72.14close November 3, 2026
Implied change
▲ +38%
Uncertainty
Medium

How we got here: a discounted-cash-flow model of Cabot Corp's free cash flow after stock-based pay with after-tax interest added back ($365M, FY2026 Q3 TTM), growing 5% and 2.5% in the next two years (forecasts, guidance and its record), then back to 2% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$69–~$140 ; that spread sets a 25% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Cabot Corp's free cash flow after stock-based pay ( $365M, FY2026 Q3 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Cabot Corp as an operating company, with every model that fits that kind of business. Cost of equity 8.7%: the 10-year Treasury yield (4.9%) plus a beta of 0.84 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$99 ~$69–$140 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$110 ~$94–$130 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$140 ~$100–$190 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$120 ~$100–$140 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$110 ~$99–$140 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Cabot Corp with Specialty Chemicals in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −32%
  • Revenue growth 5 points higher ▲ +42%
  • Free-cash-flow margin 1 point lower ▼ −13%
  • Last year's free-cash-flow margin change, if it persists ▼ −16%
  • Discount rate 1 point higher ▼ −18%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $80$116$164$228$311$418
8.5% $56$82$117$162$222$298
10% $41$62$88$123$168$226

Valuation multiples over time Market data may be delayed

At fiscal year end 2016201720182019202020212022202320242025Now
Share price$41.12$44.80$51.41$38.33$31.56$45.09$58.73$65.04$106.90$74.24$75.72
Market value$2.6bn$2.8bn$3.2bn$2.3bn$1.8bn$2.6bn$3.3bn$3.7bn$6.0bn$4.0bn$4.0bn
+ Net debt (− = net cash)$728m$904m$867m$909m$964m$994m$1.2bn$1.0bn$917m$872m$1.0bn
Enterprise value$3.3bn$3.7bn$4.0bn$3.2bn$2.8bn$3.6bn$4.6bn$4.7bn$6.9bn$4.9bn$5.0bn
Multiples
Price / sales 1.1x1.0x1.0x0.7x0.7x0.8x0.8x0.9x1.5x1.1x1.1x
Price / earnings 17.6x11.3x—14.4x—10.2x16.0x8.3x15.7x12.2x21.0x
Price / free cash flow 9.2x14.0x46.0x16.2x10.1x41.3x—10.5x13.2x10.3x14.2x
EV / EBITDA 8.1x7.5x13.8x7.0x15.4x5.8x8.6x7.0x9.0x6.3x7.4x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

68 /100

Moderate moat

How hard Cabot's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 20 / 20

    Cash operating profit has been a median 15.0% of total assets over 10 years.

  • Pricing power 9 / 20

    Gross margin has been a median 23.1%, moving by 2.0 percentage points (standard deviation) across 10 years.

  • Durability 7 / 20

    Operating margin has been a median 11.4%; its worst year was 3.7%.

  • Cash conversion 13 / 20

    Free cash flow was positive in 9 of 10 years, at a median 7.0% of revenue.

  • Discipline 19 / 20

    The diluted share count fell 7.0% over five years; stock-based pay has been a median 0.5% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $7.01 +9% $3.8bn +2%
Next $7.63 +9% $3.9bn +4%

Next year's EPS estimate has moved −0.3% in 90 days, across 5 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −0.3% on 90 days ago. In the last 30 days, 1 analyst raised Cabot Corp's forecast and 0 cut it.

Consensus EPS forecast Cabot Corp, last 90 days
$6.80 $7.00 $7.20 $7.40 $7.60 $7.80 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $7.03 Current fiscal year, 60 days ago: $6.99 Current fiscal year, 30 days ago: $6.99 Current fiscal year, 7 days ago: $6.99 Current fiscal year, Now: $7.01 $7.01 Next fiscal year, 90 days ago: $7.65 Next fiscal year, 60 days ago: $7.58 Next fiscal year, 30 days ago: $7.58 Next fiscal year, 7 days ago: $7.59 Next fiscal year, Now: $7.63 $7.63

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $7.03$7.65
60 days ago $6.99$7.58
30 days ago $6.99$7.58
7 days ago $6.99$7.59
Now $7.01$7.63

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $1.54 $1.61 +4.6%
Jun 2026 $1.66 $1.67 +0.7%
Mar 2026 $1.47 $1.61 +9.8%
Dec 2025 $1.38 $1.53 +10.8%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 3, 2026
  • Adjusted EPS fiscal 2026 $6.15 to $6.45 Non-GAAP Narrowed
    “Given the year-to-date performance and our expectations for the fourth fiscal quarter, we are tightening our fiscal 2026 Adjusted EPS guidance range from $6.00 to $6.50 per share to $6.15 to $6.45 per share."” source
  • EBITDA · Battery Materials product line fiscal 2026 about $40m Non-GAAP Maintained
    “We are pleased with the continued momentum in battery materials this fiscal year and reaffirm our expectation of approximately $40 million of EBITDA in fiscal 2026."” source
  • operating tax rate fiscal 2026 28% to 30% Non-GAAP
    “On a year-to-date basis, the Company's operating tax rate was 29% as of June 30, 2026, and we expect our full-year fiscal 2026 operating tax rate to be in the range of 28% to 30%.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows Cabot Corp's revenue by +5.0% next year and +2.5% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+6.5%, weight 65%) and the company's own record (+2.0%, weight 35%) . How the weights are set.

Analyst recommendations

6 analysts, Nov 2026
Buy233%
Hold350%
Sell117%

Monthly trend

  1. Nov 20262316
  2. Oct 20262316

Counts of recommendations published by analysts covering Cabot Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
13.0%
of tradable shares
Days to cover
11.76
at average volume
Short interest, 1 month
+6%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
1.4%
of shares
Employees
4,064
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +14.9%

$65.88 on October 31, 2025 to $75.72

ThenNowEffect
Revenue (last 12 months) $3.8bn $3.6bn −4.7%
Net margin 11.1% 5.2% −53.1%
P/E multiple 8.5x 21.0x +147.7%
Share count 55m 53m +3.8%

Biggest factor: p/e multiple.

Last 3 years +18.8%

$63.76 on November 3, 2023 to $75.72

ThenNowEffect
Revenue (last 12 months) $4.1bn $3.6bn −10.9%
Net margin 7.5% 5.2% −30.1%
P/E multiple 11.9x 21.0x +77.0%
Share count 57m 53m +7.7%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
CBT+28%+21%+28%+11%−26%+16%
Industry peers (median)+17%−26%−9%+6%−13%+5%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
CBT50%42%50%58%25%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
CBT−25%−22%−23%−22%−36%−22%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 67% from January 26, 2018 to March 20, 2020. Getting back needed a 205% gain, reached on May 6, 2021, 412 days after the low.

Price behaviour

52-week range
$57.31 – $92.88
From 52-week high
−18.5%
vs 50-day average
−2.6%
vs 200-day average
−4.1%
Volatility (1 year)
33%
Beta vs S&P 500
0.50

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
7 up, 4 down
typical move ±7.1%
After a week
8 up, 3 down
typical move ±6.3%
After a month
6 up, 5 down
typical move ±7.0%
Results releasedNext dayS&P 500 next day5 days21 days
August 3, 2026 −6.9% +3.3% −1.8% −7.9%
May 5, 2026 +8.6% +2.2% +11.4% +10.1%
February 3, 2026 +8.1% −1.3% +4.0% +2.2%
November 3, 2025 −9.2% −1.0% −9.5% −3.7%
August 4, 2025 +11.2% +1.0% +5.3% +12.3%
May 6, 2025 −5.8% −0.4% −1.4% −2.7%
February 4, 2025 +2.8% +1.1% +1.3% −0.4%
November 4, 2024 −0.1% +1.0% +6.9% −0.9%
August 5, 2024 +12.6% −2.0% +5.9% +13.1%
May 6, 2024 +7.4% +1.1% +8.6% +5.1%
February 5, 2024 +5.8% −0.1% +12.7% +18.9%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Cabot Corp’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: fundamentals grade B (needs B+ or better).

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: the shares trade below our fair value: a collar caps upside the model expects.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Cabot Corp in five measures

Fundamentals grade B
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Cabot Corp
$3.4B $3.6B $3.8B $4B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $3.9B Revenue (TTM), FY24 Q1: $3.9B Revenue (TTM), FY24 Q2: $3.9B Revenue (TTM), FY24 Q3: $4B Revenue (TTM), FY24 Q4: $4B Revenue (TTM), FY25 Q1: $4B Revenue (TTM), FY25 Q2: $3.9B Revenue (TTM), FY25 Q3: $3.8B Revenue (TTM), FY25 Q4: $3.7B Revenue (TTM), FY26 Q1: $3.6B Revenue (TTM), FY26 Q2: $3.6B Revenue (TTM), FY26 Q3: $3.6B $3.6B

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $3.9B
FY24 Q1 $3.9B
FY24 Q2 $3.9B
FY24 Q3 $4B
FY24 Q4 $4B
FY25 Q1 $4B
FY25 Q2 $3.9B
FY25 Q3 $3.8B
FY25 Q4 $3.7B
FY26 Q1 $3.6B
FY26 Q2 $3.6B
FY26 Q3 $3.6B
Revenue growth, TTM YoY Cabot Corp
-10% -5% 0% 5% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: -9.0% Revenue growth, TTM YoY, FY24 Q1: -9.1% Revenue growth, TTM YoY, FY24 Q2: -8.2% Revenue growth, TTM YoY, FY24 Q3: -2.9% Revenue growth, TTM YoY, FY24 Q4: 1.6% Revenue growth, TTM YoY, FY25 Q1: 1.7% Revenue growth, TTM YoY, FY25 Q2: -0.1% Revenue growth, TTM YoY, FY25 Q3: -3.6% Revenue growth, TTM YoY, FY25 Q4: -7.0% Revenue growth, TTM YoY, FY26 Q1: -9.6% Revenue growth, TTM YoY, FY26 Q2: -8.5% Revenue growth, TTM YoY, FY26 Q3: -4.7% -4.7%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 -9.0%
FY24 Q1 -9.1%
FY24 Q2 -8.2%
FY24 Q3 -2.9%
FY24 Q4 1.6%
FY25 Q1 1.7%
FY25 Q2 -0.1%
FY25 Q3 -3.6%
FY25 Q4 -7.0%
FY26 Q1 -9.6%
FY26 Q2 -8.5%
FY26 Q3 -4.7%
Operating margin (TTM) Cabot Corp
13% 14% 15% 16% 17% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: 13.4% Operating margin (TTM), FY24 Q1: 14.2% Operating margin (TTM), FY24 Q2: 14.9% Operating margin (TTM), FY24 Q3: 15.3% Operating margin (TTM), FY24 Q4: 15.4% Operating margin (TTM), FY25 Q1: 15.9% Operating margin (TTM), FY25 Q2: 16.4% Operating margin (TTM), FY25 Q3: 16.6% Operating margin (TTM), FY25 Q4: 16.7% Operating margin (TTM), FY26 Q1: 16.5% Operating margin (TTM), FY26 Q2: 15.7% Operating margin (TTM), FY26 Q3: 13.6% 13.6%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 13.4%
FY24 Q1 14.2%
FY24 Q2 14.9%
FY24 Q3 15.3%
FY24 Q4 15.4%
FY25 Q1 15.9%
FY25 Q2 16.4%
FY25 Q3 16.6%
FY25 Q4 16.7%
FY26 Q1 16.5%
FY26 Q2 15.7%
FY26 Q3 13.6%
FCF margin (TTM) Cabot Corp
6% 8% 10% 12% 14% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 8.9% FCF margin (TTM), FY24 Q1: 9.8% FCF margin (TTM), FY24 Q2: 10.4% FCF margin (TTM), FY24 Q3: 10.1% FCF margin (TTM), FY24 Q4: 11.3% FCF margin (TTM), FY25 Q1: 11.2% FCF margin (TTM), FY25 Q2: 8.1% FCF margin (TTM), FY25 Q3: 9.1% FCF margin (TTM), FY25 Q4: 10.5% FCF margin (TTM), FY26 Q1: 11.1% FCF margin (TTM), FY26 Q2: 12.1% FCF margin (TTM), FY26 Q3: 7.7% 7.7%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 8.9%
FY24 Q1 9.8%
FY24 Q2 10.4%
FY24 Q3 10.1%
FY24 Q4 11.3%
FY25 Q1 11.2%
FY25 Q2 8.1%
FY25 Q3 9.1%
FY25 Q4 10.5%
FY26 Q1 11.1%
FY26 Q2 12.1%
FY26 Q3 7.7%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Cabot took in during FY2025, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.

  1. Revenue $3.7B
  2. Cost of revenue $2.8B · 74.7%
  3. Gross profit $940M · 25.3%
  4. Research and development $59M · 1.6%
  5. Selling, general and admin $260M · 7.0%
  6. Operating income $621M · 16.7%
  7. Income tax $196M · 5.3%
  8. Interest and other $94M · 2.5%
  9. Net income $331M · 8.9%

Shares of revenue. Source: Cabot's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Sept 2009 2010 Sept 2010 2011 Sept 2011 2012 Sept 2012 2013 Sept 2013 2014 Sept 2014 2015 Sept 2015 2016 Sept 2016 2017 Sept 2017 2018 Sept 2018 2019 Sept 2019 2020 Sept 2020 2021 Sept 2021 2022 Sept 2022 2023 Sept 2023 2024 Sept 2024 2025 Sept 2025 LTM Jun 2026
Income
Revenue 2,108 2,716 3,102 3,291 3,456 3,647 2,871 2,411 2,717 3,242 3,337 2,614 3,409 4,321 3,931 3,994 3,713 3,634
Gross profit 217 510 558 644 633 721 585 575 657 772 685 500 799 885 839 960 940 825
EBITDA 110 341 385 445 458 536 −134 408 493 293 454 179 614 535 670 765 775 673
Operating income −54 204 243 291 268 335 −317 247 338 144 306 21 454 389 526 614 621 493
Net income −77 154 236 388 153 199 −334 147 248 −113 157 −238 250 209 445 380 331 190
Diluted EPS −$1.25 $2.35 $3.57 $5.99 $2.36 $3.03 −$5.27 $2.32 $3.91 −$1.85 $2.63 −$4.21 $4.34 $3.62 $7.73 $6.72 $6.02 $3.61
Growth (year on year)
Revenue −33.9% +28.8% +14.2% +6.1% +5.0% +5.5% −21.3% −16.0% +12.7% +19.3% +2.9% −21.7% +30.4% +26.8% −9.0% +1.6% −7.0% −4.7%
EBITDA −66.4% +210.0% +12.9% +15.6% +2.9% +17.0% −125.0% — +20.8% −40.6% +54.9% −60.6% +243.0% −12.9% +25.2% +14.2% +1.3% −14.3%
Operating income −132.9% — +19.1% +19.8% −7.9% +25.0% −194.6% — +36.8% −57.4% +112.5% −93.1% — −14.3% +35.2% +16.7% +1.1% −22.2%
Net income −189.5% — +53.2% +64.4% −60.6% +30.1% −267.8% — +68.7% −145.6% — −251.6% — −16.4% +112.9% −14.6% −12.9% −55.3%
Diluted EPS −194.7% — +51.9% +67.8% −60.6% +28.4% −273.9% — +68.5% −147.3% — −260.1% — −16.6% +113.5% −13.1% −10.4% −53.6%
Margins
Gross margin 10.3% 18.8% 18.0% 19.6% 18.3% 19.8% 20.4% 23.8% 24.2% 23.8% 20.5% 19.1% 23.4% 20.5% 21.3% 24.0% 25.3% 22.7%
EBITDA margin 5.2% 12.6% 12.4% 13.5% 13.3% 14.7% −4.7% 16.9% 18.1% 9.0% 13.6% 6.8% 18.0% 12.4% 17.0% 19.2% 20.9% 18.5%
Operating margin −2.6% 7.5% 7.8% 8.8% 7.8% 9.2% −11.0% 10.2% 12.4% 4.4% 9.2% 0.8% 13.3% 9.0% 13.4% 15.4% 16.7% 13.6%
Net margin −3.7% 5.7% 7.6% 11.8% 4.4% 5.5% −11.6% 6.1% 9.1% −3.5% 4.7% −9.1% 7.3% 4.8% 11.3% 9.5% 8.9% 5.2%
Free-cash-flow margin 13.9% 5.2% −1.1% 4.1% 4.5% 3.9% 12.5% 11.6% 7.4% 2.1% 4.2% 6.8% 1.8% −2.6% 8.9% 11.3% 10.5% 7.7%
Cash flow
Cash from operations 399 249 195 415 419 315 499 392 348 298 363 377 257 100 595 692 665 497
Capital spending 106 108 230 281 264 171 141 112 147 229 224 200 195 211 244 241 274 216
Free cash flow 293 141 −35 134 155 144 358 280 201 69 139 177 62 −111 351 451 391 281
Stock-based pay 27 27 19 18 16 14 12 17 16 22 11 9 21 23 20 25 24 18
Free cash flow after stock pay 266 114 −54 116 139 130 346 263 185 47 128 168 41 −134 331 426 367 263
Balance sheet
Cash 304 387 286 120 95 67 77 200 280 175 169 151 168 206 238 223 258 250
Total debt 657 652 755 1,604 1,314 1,097 995 928 1,184 1,042 1,078 1,115 1,162 1,443 1,276 1,140 1,130 1,273
Net debt (negative = net cash) 353 265 469 1,484 1,219 1,030 918 728 904 867 909 964 994 1,237 1,038 917 872 1,023
Diluted shares 63m 64m 65m 64m 65m 65m 63m 63m 63m 62m 59m 57m 57m 57m 57m 56m 54m 53m
Returned to shareholders
Dividends 48 47 47 49 51 54 56 65 77 80 80 80 80 84 88 93 96 97
Buybacks 2 5 59 36 6 18 101 45 61 142 173 44 3 53 98 172 168 140
Total returned 50 52 106 85 57 72 157 110 138 222 253 124 83 137 186 265 264 237

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

4 of 6 checks passed · June 30, 2026
What it owns · $4.0bn
Short-term assets $1.7bnLonger-term assets $2.3bn
What it owes, and who funded it · $2.7bn
Short-term liabilities $1.1bnShareholders' equity $1.6bn
  • Short-term assets cover short-term liabilities $1.7bn of assets due within a year against $1.1bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities Not assessable from the reported split. Not assessable.
  • More cash than debt $250m of cash against $1.1bn of debt.
  • Debt below 40% of shareholders' equity Debt is 68% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 90% to 68% over five years.
  • A year's operating cash flow covers at least 20% of debt $497m of operating cash flow against $1.1bn of debt.
  • Operating profit covers interest at least five times over Operating income of $493m against $74m of interest.

From Cabot Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q3 TTM
Buybacks (TTM)
$140M
Dividends (TTM)
$97M
Returned to shareholders
84%
of free cash flow
Buybacks, last 3 fiscal years
$438M
Diluted share count
−3.7%
year over year
Total shareholder yield
6.1%
dividends 2.5% + buybacks 3.6% of market value
Dividend payout ratio
51%
of net income paid out
R&D spending
1.5%
of revenue
Sales & admin spending
7.6%
of revenue

Competitors: side by side with peers

Closest by revenue in specialty chemicals
Last 12 months unless stated CBT FUL ESI AVNT NEU AXTA Median
Revenue, last 12 months $3.6bn $3.6bn $3.5bn $3.3bn $2.8bn $5.2bn $906m
Revenue growth, last 12 months −4.7% 1.5% 39.6% 2.4% 0.9% 0.1% 5.4%
Revenue growth, 3-year average −3.8% −0.1% 14.4% 0.5% 0.4% 0.3% 0.9%
Revenue growth, latest quarter 6.4% 5.2% 51.7% 5.8% 3.8% 1.8% 8.3%
Gross margin 22.7% 32.3% 36.6% 31.7% 31.7% 33.6% 28.8%
Operating margin 13.6% 9.5% 11.7% 9.5% 20.2% 12.4% 4.3%
Operating margin, 3-year average 15.2% 9.9% 13.0% 8.4% 20.3% 13.3% 5.5%
Net margin 5.2% 5.6% 5.9% 5.1% 16.5% 6.5% 0.8%
Cash from operations / revenue 13.7% 8.1% 8.1% 9.0% 18.1% 13.5% 6.9%
Free-cash-flow margin 7.7% 2.8% 5.2% 5.7% 13.8% 9.6% 4.3%
Free-cash-flow margin, 3-year average 9.0% 4.5% 9.1% 5.1% 16.4% 8.7% 5.1%
Stock pay / revenue 0.5% 0.7% 2.2% 0.3% 0.1% 0.6% 1.0%
Change in share count −3.7% −0.9% 0.4% 0.2% −1.9% −1.6% 0.1%

Median of all 42 companies we cover in specialty chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

42 specialty chemicals companies
Measure Company Peer median Rank
Revenue growth Growth -4.7% 6.0% 34 of 42
Change in growth rate Growth +3.8pp +1.3pp 12 of 42
Gross margin Profitability 22.7% 31.5% 27 of 40
Operating margin Profitability 13.6% 3.8% 5 of 39
Net margin Profitability 5.2% 1.7% 15 of 42
Free-cash-flow margin Cash generation 7.7% 4.8% 12 of 42
Stock pay as % of revenue Cash generation 0.5% 1.0% 9 of 36
Long-term debt as % of assets Balance sheet 20.8% 26.8% 14 of 36
Change in share count Balance sheet -3.7% 0.0% 2 of 37

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to September 30, 2025
Geography
Region Revenue YoY
Other Foreign Countries $2.1B ▼ 7.3%
Asia Pacific $1.4B ▼ 7.9%
Americas $1.3B ▼ 8.2%
China $931M ▼ 5.3%
EMEA $873M ▼ 3.5%
United States $670M ▼ 8.6%

These categories overlap or exclude eliminations, so shares aren't shown.

From Cabot Corp's 10-K filed November 24, 2025, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$4.9B
Institutions reporting
388
Shares held vs prior quarter
▲ 5.3%
Positions opened / closed
52 / 39

Top buyers and sellers, Q2 2026: 200 institutions bought and 141 sold ; the biggest buyer was American Century Companies Inc (+531K shares) and the biggest seller Wellington Management Group LLP (−1.1M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $633M 7.0M 12.9% ▲ 5.4%
Earnest Partners LLC $304M 3.3M 6.2% ▲ 5.9%
Vanguard Portfolio Management LLC $279M 3.1M 5.7% ▼ 1.4%
American Century Companies Inc $251M 2.8M 5.1% ▲ 23.7%
Wellington Management Group LLP $219M 2.4M 4.5% ▼ 32.2%
Vanguard Capital Management LLC $211M 2.3M 4.3% ▼ 0.1%
State Street Corp $197M 2.2M 4.0% ▲ 6.8%
Fuller & Thaler Asset Management, Inc. $182M 2.0M 3.7% ▼ 2.2%
Dimensional Fund Advisors LP $175M 1.9M 3.6% ▲ 10.5%
Geode Capital Management, LLC $162M 1.8M 3.3% ▲ 31.3%
Bank Of America Corp $151M 1.7M 3.1% ▲ 9.5%
FMR LLC $142M 1.6M 2.9% ▲ 14.5%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Cabot Corp's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $19.6M 3 trades by 1 insider · 0% under pre-set plans
Net ▼ $19.6M net selling
Insider Date Trade Shares Price Value
Keohane Sean D President and CEO August 28, 2026 Sell 134,895 $85.00 $11.5M
Keohane Sean D President and CEO August 24, 2026 Sell 2,779 $85.50 $237,604
Keohane Sean D President and CEO August 7, 2026 Sell 91,923 $86.41 $7.9M

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 3 trades and filings

No trades in Cabot Corp disclosed in the last 12 months; 3 earlier trades on record.

  • Lois Frankel(D-FL 21):Sale (full), $1,001 - $15,000, traded December 4, 2019, filed December 20, 2019
  • Lois Frankel(D-FL 21):Sale (partial), $1,001 - $15,000, traded December 3, 2019, filed December 20, 2019
  • Thomas MacArthur(NJ):Sale (full), $1,001 - $15,000, traded May 27, 2015, filed June 7, 2015

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around February 2, 2027 estimated from the company's past filing pattern, not announced

  • November 2, 2026
  • August 3, 2026
  • May 5, 2026
  • February 3, 2026
  • November 3, 2025
  • August 4, 2025

Recent SEC filings

Data status

When each part of this page on Cabot Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Cabot Corp in brief

What does Cabot Corp do?
Cabot Corp is a US-listed company in the specialty chemicals industry. Its financial year ends in September.
What is Cabot Corp's stock ticker?
Cabot Corp trades under the ticker CBT on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Cabot Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Cabot Corp reported revenue of $3.6B, 4.7% lower than a year earlier, according to its SEC filings.
What is Cabot Corp's free cash flow?
Cabot Corp's free-cash-flow margin is 7.7% of revenue over the trailing twelve months, ranking 12 of the 42 specialty chemicals companies we cover.
What is Cabot Corp's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Cabot Corp's free cash flow after stock-based pay gives ~$99 per share in the base case, and ~$69–$140 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Cabot Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Earnest Partners LLC and Vanguard Portfolio Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Cabot Corp buying back stock, and does it pay a dividend?
Cabot Corp spent $140M on share repurchases over the trailing twelve months, and its diluted share count fell 3.7% over the year.
What is Cabot Corp's market cap?
On November 2, 2026, Cabot Corp's market capitalisation was about $4B, with a price-to-earnings ratio of 21.0 and net debt of $1B. Market figures come from third-party market data and may be delayed.
Does Cabot Corp pay a dividend?
Yes: Cabot Corp paid $97M in dividends over the trailing twelve months, a dividend yield of 2.48% and a payout ratio of 51.1%.
How much debt does Cabot Corp have?
Cabot Corp's debt-to-equity ratio is 67.9%, from its latest balance sheet (89.9% five years earlier). The financial health section below sets out its other solvency checks.
Who are Cabot Corp's competitors?
In our Specialty Chemicals peer group, the companies closest to Cabot Corp are Fuller H B Co, Element Solutions Inc, Avient Corp, Newmarket Corp and Axalta Coating Systems Ltd. The side-by-side comparison below sets their revenue, margins and growth against Cabot Corp's.
Are insiders buying or selling Cabot Corp stock?
Over the last 12 months, Cabot Corp's directors and officers reported 0 open-market purchases and 3 sales on Form 4. The insider trading page charts every trade.
When is Cabot Corp's next earnings date?
Around February 2, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Cabot Corp announces its own schedule.